Anaesthesia application modes compared

Article

Contact anaesthesia is just as safe and effective as peribulbar application for combined cataract and glaucoma surgery, according to study results published online ahead of print by Ophthalmologica.

Contact anaesthesia is just as safe and effective as peribulbar application for combined cataract and glaucoma surgery, according to study results published online ahead of print by Ophthalmologica.

Luis E. Pablo of the Department of Ophthalmology at Miguel Servet University Hospital, Zaragoza, Spain and colleagues conducted a randomized study of patients undergoing phacotrabeculectomy (n=120), assessing pain, complications and success of surgery and comparing the results obtained by patients receiving topical contact anaesthesia with those obtained from peribulbar anaesthesia injection.

The team found that peribulbar injection was associated with more pain than topical anaesthesia at the time of application; during and after surgery, however, there was no difference in the levels of pain experienced by the separate groups. In terms of both tension and visual acuity, there was again no difference between the groups treated with the different application methods.

Therefore the researchers concluded that, during surgery and in the mid- to long-term, topical anaesthesia application and peribulbar application are associated with similar outcomes and levels of pain.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
© 2025 MJH Life Sciences

All rights reserved.